Search hospitals > New York > Commack
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Claim this profileCommack, New York 11725
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for MEK1 Gene Mutation
Conducts research for MEK2 Gene Mutation
6 reported clinical trials
3 medical researchers
Summary
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is a medical facility located in Commack, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, MEK1 Gene Mutation, MEK2 Gene Mutation and other specialties. Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is involved with conducting 6 clinical trials across 14 conditions. There are 3 research doctors associated with this hospital, such as Yelena Janjigian, MD, Paul Paik, and Audree Tadros, MD.Area of expertise
1Breast Cancer
adult
solid tumor cancer
known therapy
2Lung Cancer
Stage III
Stage II
HBV DNA negative
Top PIs
Yelena Janjigian, MDMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)6 years of reported clinical research
Studies Esophageal Cancer
Studies Stomach Cancer
6 reported clinical trials
11 drugs studied
Paul PaikMemorial Sloan Kettering Westchester (All Protocol Activities)5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
12 drugs studied
Audree Tadros, MDMemorial Sloan Kettering Cancer Center3 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
3 drugs studied
Clinical Trials running at Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Lung Cancer
Breast Cancer
Esophageal Cancer
Cervical Adenocarcinoma
Stomach Cancer
Breast cancer
Certolizumab + Chemotherapy + Nivolumab
for Lung Cancer
The purpose of the study is to explore adding the study drug certolizumab to standard chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy more effective in shrinking the cancer. This study will examine whether adding certolizumab to the usual treatment approach is better than, the same as, or worse than the usual approach alone.
Recruiting1 award Phase 214 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.